Anthony P. Adamis

26.5k total citations · 11 hit papers
114 papers, 21.2k citations indexed

About

Anthony P. Adamis is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Anthony P. Adamis has authored 114 papers receiving a total of 21.2k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Ophthalmology, 50 papers in Radiology, Nuclear Medicine and Imaging and 40 papers in Molecular Biology. Recurrent topics in Anthony P. Adamis's work include Retinal Diseases and Treatments (68 papers), Glaucoma and retinal disorders (28 papers) and Retinal Imaging and Analysis (24 papers). Anthony P. Adamis is often cited by papers focused on Retinal Diseases and Treatments (68 papers), Glaucoma and retinal disorders (28 papers) and Retinal Imaging and Analysis (24 papers). Anthony P. Adamis collaborates with scholars based in United States, Germany and Japan. Anthony P. Adamis's co-authors include David R. Guyer, David T. Shima, Evangelos S. Gragoudas, Napoleone Ferrara, Antonia M. Joussen, Eugene W. M. Ng, Emmett T. Cunningham, Jayakrishna Ambati, Vassiliki Poulaki and Bernd Kirchhof and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Anthony P. Adamis

112 papers receiving 20.4k citations

Hit Papers

Pegaptanib for Neovascular Age-Related Macular Degeneration 1996 2026 2006 2016 2004 2006 2004 2016 2003 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pegaptanib for Neovascular Age-Related Macular Degeneration
    2004 1.8k citations Evangelos S. Gragoudas, Anthony P. Adamis et al. profile →
  2. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
    2006 1.2k citations David T. Shima, Anthony P. Adamis et al. profile →
  3. A central role for inflammation in the pathogenesis of diabetic retinopathy
    2004 963 citations Antonia M. Joussen, Vassiliki Poulaki et al. profile →
  4. Ten years of anti-vascular endothelial growth factor therapy
    2016 759 citations Napoleone Ferrara, Anthony P. Adamis profile →
  5. Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies
    2003 748 citations Jayakrishna Ambati, Balamurali K. Ambati et al. Survey of Ophthalmology profile →
  6. Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials
    2013 650 citations Anthony P. Adamis, Jason S. Ehrlich et al. Ophthalmology profile →
  7. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition
    1999 634 citations Lloyd Paul Aiello, Anthony P. Adamis et al. profile →
  8. Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic Injury
    2007 591 citations Anthony P. Adamis, David T. Shima et al. American Journal Of Pathology profile →
  9. Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman Primate
    1996 471 citations Anthony P. Adamis profile →
  10. A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema
    2005 454 citations Anthony P. Adamis, Lloyd Paul Aiello et al. Ophthalmology profile →
  11. Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
    2011 376 citations Peter A. Campochiaro, Anthony P. Adamis et al. Ophthalmology profile →

Peers

Anthony P. Adamis
Peter A. Campochiaro United States
Joan W. Miller United States
Reinier O. Schlingemann Netherlands
Antonia M. Joussen Germany
Gerard A. Lutty United States
Anselm Kampik Germany
Karl G. Csaky United States
Jayakrishna Ambati United States
David S. Boyer United States
Rajendra S. Apte United States
Peter A. Campochiaro United States
Anthony P. Adamis
Citations per year, relative to Anthony P. Adamis Anthony P. Adamis (= 1×) peers Peter A. Campochiaro

Countries citing papers authored by Anthony P. Adamis

Since Specialization
Citations

This map shows the geographic impact of Anthony P. Adamis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony P. Adamis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony P. Adamis more than expected).

Fields of papers citing papers by Anthony P. Adamis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony P. Adamis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony P. Adamis. The network helps show where Anthony P. Adamis may publish in the future.

Co-authorship network of co-authors of Anthony P. Adamis

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony P. Adamis. A scholar is included among the top collaborators of Anthony P. Adamis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony P. Adamis. Anthony P. Adamis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartnett, M. Elizabeth, Ward Fickweiler, Anthony P. Adamis, et al.. (2024). Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease. SHILAP Revista de lepidopterología. 4(5). 100521–100521. 4 indexed citations
2.
Wells, John A., Charles C. Wykoff, Jeffrey R. Willis, et al.. (2021). Efficacy, durability, and safety of faricimab in diabetic macular edema (DME): one-year results from the phase 3 YOSEMITE and RHINE trials. Investigative Ophthalmology & Visual Science. 62(8). 1037–1037. 2 indexed citations
3.
Holekamp, Nancy M., Peter A. Campochiaro, Margaret Chang, et al.. (2021). Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. 129(3). 295–307. 121 indexed citations
4.
Wright, Matthew B., et al.. (2013). The dual PPAR-α/γ agonist aleglitazar attenuates retinopathy in streptozotocin diabetic rats. Investigative Ophthalmology & Visual Science. 54(15). 4596–4596. 1 indexed citations
5.
Adamis, Anthony P., et al.. (2010). The Case for Complement and Inflammation in AMD: Open Questions. Advances in experimental medicine and biology. 703. 1–7. 9 indexed citations
6.
Shi, Junxia, Sandeep Jain, Harris Ripps, et al.. (2009). Impediments to eye transplantation: ocular viability following optic-nerve transection or enucleation. British Journal of Ophthalmology. 93(9). 1134–1140. 24 indexed citations
7.
Adamis, Anthony P.. (2009). THE RATIONALE FOR DRUG COMBINATIONS IN AGE-RELATED MACULAR DEGENERATION. Retina. 29(6). S42–S44. 9 indexed citations
8.
Starita, Carla, Manju Patel, Barrett Katz, & Anthony P. Adamis. (2007). Vascular Endothelial Growth Factor and the Potential Therapeutic Use of Pegaptanib (Macugen®) in Diabetic Retinopathy. Developments in ophthalmology. 39. 122–148. 55 indexed citations
9.
Christoforidis, John, Anthony P. Adamis, & Donald J. D’Amico. (2005). Medical Treatment of Diabetic Macular Edema With Rofecoxib. Investigative Ophthalmology & Visual Science. 46(13). 391–391. 1 indexed citations
10.
Poulaki, Vassiliki, Antonia M. Joussen, Nicholas Mitsiades, et al.. (2004). Insulin-Like Growth Factor-I Plays a Pathogenetic Role in Diabetic Retinopathy. American Journal Of Pathology. 165(2). 457–469. 116 indexed citations
11.
Lu, Ming Y. & Anthony P. Adamis. (2004). Ocular Delivery of Angiostatic Agents. International Ophthalmology Clinics. 44(3). 41–51. 1 indexed citations
12.
Ambati, Balamurali K., Antonia M. Joussen, William A. Kuziel, Anthony P. Adamis, & Jayakrishna Ambati. (2003). Inhibition of Corneal Neovascularization by Genetic Ablation of CCR2. Cornea. 22(5). 465–467. 33 indexed citations
13.
Ambati, Jayakrishna, Balamurali K. Ambati, Sonia H. Yoo, Tsontcho Ianchulev, & Anthony P. Adamis. (2003). Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies. Survey of Ophthalmology. 48(3). 257–293. 748 indexed citations breakdown →
14.
Poulaki, Vassiliki, Wenying Qin, Antonia M. Joussen, et al.. (2002). Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF. Journal of Clinical Investigation. 109(6). 805–815. 169 indexed citations
15.
Poulaki, Vassiliki, Wenying Qin, Antonia M. Joussen, et al.. (2002). Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGF. Journal of Clinical Investigation. 109(6). 805–815. 10 indexed citations
16.
Joussen, Antonia M., Vassiliki Poulaki, Wenying Qin, et al.. (2002). Retinal Vascular Endothelial Growth Factor Induces Intercellular Adhesion Molecule-1 and Endothelial Nitric Oxide Synthase Expression and Initiates Early Diabetic Retinal Leukocyte Adhesion in Vivo. American Journal Of Pathology. 160(2). 501–509. 320 indexed citations
17.
Lu, Ming Y., Manabu Kuroki, Seiji Amano, et al.. (1998). Advanced glycation end products increase retinal vascular endothelial growth factor expression.. Journal of Clinical Investigation. 101(6). 1219–1224. 343 indexed citations
18.
Baum, Thomas, Anthony P. Adamis, & Frederick A. Jakobiec. (1997). Primary Acquired Melanosis of the Conjunctiva. International Ophthalmology Clinics. 37(4). 61–72. 4 indexed citations
19.
Tolentino, Michael J., Joan W. Miller, Evangelos S. Gragoudas, et al.. (1996). Intravitreous Injections of Vascular Endothelial Growth Factor Produce Retinal Ischemia and Microangiopathy in an Adult Primate. Ophthalmology. 103(11). 1820–1828. 415 indexed citations
20.
Navon, Samuel E. & Anthony P. Adamis. (1994). Safety During the Transition to Phacoemulsification: A Survey. International Ophthalmology Clinics. 34(3). 51–65. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter A. Campochiaro Breakdown of academic impact, for papers by Joan W. Miller Breakdown of academic impact, for papers by Reinier O. Schlingemann Breakdown of academic impact, for papers by Antonia M. Joussen Breakdown of academic impact, for papers by Gerard A. Lutty Breakdown of academic impact, for papers by Anselm Kampik Breakdown of academic impact, for papers by Karl G. Csaky Breakdown of academic impact, for papers by Jayakrishna Ambati Breakdown of academic impact, for papers by David S. Boyer Breakdown of academic impact, for papers by Rajendra S. Apte
Rankless by CCL
2026